Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 73.09% is 14% below its 5-year average of 85.20%, near the low end of its 5-year range (64.05%–100.00%).
4.52% below its 12-month average of 76.55%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 75.77%.
GROSS MARGIN
73.09%
GROSS MARGIN AVG TTM
76.55%
GROSS MARGIN AVG 3Y
81.66%
GROSS MARGIN AVG 5Y
85.20%
GROSS MARGIN AVG 10Y
92.28%
GROSS MARGIN AVG 15Y
93.22%
GROSS MARGIN AVG 20Y
96.28%
CURRENT VS TTM AVG
-4.52%
CURRENT VS 3Y AVG
-10.50%
CURRENT VS 5Y AVG
-14.21%
CURRENT VS 10Y AVG
-20.80%
CURRENT VS 15Y AVG
-21.60%
CURRENT VS 20Y AVG
-24.09%
SECTOR MEDIAN · HEALTHCARE
46.51%
median of 525 covered companies
CURRENT VS SECTOR MEDIAN
+57.15%
vs the sector median at left
Market Cap
$1.52B
Gross Margin
57.87%
TTM Avg
56.73%
3Y Avg
61.85%
5Y Avg
-49.66%
Market Cap
$1.47B
Gross Margin
17.33%
TTM Avg
13.16%
3Y Avg
12.65%
5Y Avg
13.31%
Market Cap
$1.43B
Gross Margin
98.97%
TTM Avg
9.74%
3Y Avg
-353.69%
5Y Avg
-246.22%
Market Cap
$1.65B
Gross Margin
51.01%
TTM Avg
55.14%
3Y Avg
57.28%
5Y Avg
56.79%
Market Cap
$1.40B
Gross Margin
-91.00%
TTM Avg
-566.75%
3Y Avg
-1506.60%
5Y Avg
-994.02%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Innoviva, Inc. (INVA) | $1.53B | 73.09% | 76.55% | 81.66% | 85.20% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.52B | 57.87% | 56.73% | 61.85% | -49.66% |
| GH Research PLC (GHRS)vs › | $1.51B | 0.00% | 0.00% | 0.00% | 0.00% |
| Certara, Inc. (CERT)vs › | $1.57B | 58.33% | 60.70% | 60.53% | 60.29% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.48B | N/A | N/A | N/A | N/A |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.47B | 17.33% | 13.16% | 12.65% | 13.31% |
| AnaptysBio, Inc. (ANAB)vs › | $1.43B | 98.97% | 9.74% | -353.69% | -246.22% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | 51.01% | 55.14% | 57.28% | 56.79% |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.40B | -91.00% | -566.75% | -1506.60% | -994.02% |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.40B | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
73.1%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 75.77% |
| 2026-03-31 | 77.39% |
| 2025-12-31 | 64.05% |
| 2025-09-30 | 76.09% |
| 2025-06-30 | 89.44% |
| 2025-03-31 | 90.02% |
| 2024-12-31 | 92.20% |
| 2024-09-30 | 88.84% |
| 2024-06-30 | 82.21% |
| 2024-03-31 | 85.84% |
| 2023-12-31 | 84.70% |
| 2023-09-30 | 84.66% |
| 2023-06-30 | 70.41% |
| 2023-03-31 | 69.97% |
| 2022-12-31 | 80.52% |
| 2022-09-30 | 77.10% |
| 2022-06-30 | 100.00% |
| 2022-03-31 | 100.00% |
| 2021-12-31 | 100.00% |
| 2021-09-30 | 100.00% |
| 2021-06-30 | 99.96% |
| 2021-03-31 | 99.94% |
| 2020-12-31 | 99.76% |
| 2020-09-30 | 100.00% |
| 2020-06-30 | 100.00% |
| 2020-03-31 | 100.00% |
| 2019-12-31 | 100.00% |
| 2019-09-30 | 100.00% |
| 2019-06-30 | 100.00% |
| 2019-03-31 | 100.00% |
| 2018-12-31 | 100.00% |
| 2018-09-30 | 100.00% |
| 2018-06-30 | 100.00% |
| 2018-03-31 | 100.00% |
| 2017-12-31 | 99.51% |
| 2017-09-30 | 99.36% |
| 2017-06-30 | 99.41% |
| 2017-03-31 | 99.13% |
| 2016-12-31 | 99.21% |
| 2016-09-30 | 99.14% |
| 2016-06-30 | 98.86% |
| 2016-03-31 | 98.38% |
| 2015-12-31 | 96.84% |
| 2015-09-30 | 95.97% |
| 2015-06-30 | 94.01% |
| 2015-03-31 | 89.68% |
| 2014-12-31 | 89.33% |
| 2014-09-30 | -91.09% |
| 2014-06-30 | -127.52% |
| 2014-03-31 | -13.94% |
| 2013-12-31 | -3503.16% |
| 2013-09-30 | -384.74% |
| 2013-06-30 | 1755.24% |
| 2013-03-31 | -1865.48% |
| 2012-12-31 | -384.99% |
| 2012-09-30 | -1789.93% |
| 2012-06-30 | 100.00% |
| 2012-03-31 | 100.00% |
| 2011-12-31 | 100.00% |
| 2011-09-30 | 100.00% |
| 2011-06-30 | 100.00% |
| 2011-03-31 | 100.00% |
| 2010-12-31 | 100.00% |
| 2010-09-30 | 100.00% |
| 2010-06-30 | 100.00% |
| 2010-03-31 | 100.00% |
| 2009-12-31 | 100.00% |
| 2009-09-30 | 100.00% |
| 2009-06-30 | 100.00% |
| 2009-03-31 | 100.00% |
| 2008-12-31 | 100.00% |
| 2008-09-30 | 100.00% |
| 2008-06-30 | 100.00% |
| 2008-03-31 | 100.00% |
| 2007-12-31 | 100.00% |
| 2007-09-30 | 100.00% |
| 2007-06-30 | 100.00% |
| 2007-03-31 | 100.00% |
| 2006-12-31 | 100.00% |
| 2006-09-30 | 100.00% |
| 2006-06-30 | 100.00% |
| 2006-03-31 | 100.00% |
| 2005-12-31 | 100.00% |
| 2005-09-30 | 100.00% |
| 2005-06-30 | 100.00% |
| 2005-03-31 | 100.00% |
| 2004-12-31 | 100.00% |
| 2004-09-30 | 100.00% |
| 2004-06-30 | 100.00% |
